US FDA Panel Meeting Set For Alzheimer’s Device Treatment
Executive Summary
An Alzheimer’s treatment device from Israeli firm Neuronix Ltd has landed a date with US FDA’s Neurological Devices Panel. The committee will discuss the neuroAD Therapy System on March 21.